Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine compounds as GlyT1 inhibitors

Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine compounds as GlyT1 inhibitors

US Patent 9708334 · Granted Jul 18, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bolter miner and tunneling system2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Chemoembolization agents2025
Modulators of cystic fibrosis transmembrane conductance regulator2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors2025
Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors2025
Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors2025
Modulators of cystic fibrosis transmembrane conductance regulator2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof2024
Substituted furanopyrimidine compounds as PDE1 inhibitors2024